Global Biopsy Devices Market to Reach USD 10.81 Billion by 2032, Driven by Rising Cancer Burden and Technological Advancements, states DelveInsight

The global biopsy devices market is poised for significant growth, with market size projected to increase from USD 5,813.16 million in 2024 to USD 10,812.77 million by 2032, expanding at a CAGR of 8.09% during 2025-2032. The robust expansion is being driven by the growing incidence of cancers, rising demand for minimally invasive diagnostic procedures, and rapid advancements in biopsy technologies.

Biopsy devices play a crucial role in disease diagnosis by enabling tissue and cell sample collection for laboratory examination. While cancer remains the primary focus, these devices are also widely used to assess infectious, inflammatory, and neurological disorders. The increasing prevalence of breast, lung, prostate, and colorectal cancers worldwide has created an urgent need for accurate diagnostic solutions, positioning the biopsy devices market as a critical segment within the global healthcare diagnostics landscape.

Get access to detailed forecasts, segment analysis, and competitive intelligence on the global biopsy devices market. Request Sample Report Now - https://www.delveinsight.com/report-store/biopsy-devices-market?utm_source=openpr&utm_medium=press-release&utm_campaign=apr

Biopsy Devices Market Drivers
Rising Cancer Incidence
Cancer continues to be one of the leading causes of mortality globally, creating sustained demand for biopsy devices. Biopsies remain the gold standard for cancer diagnosis and staging, essential for developing effective treatment strategies. For instance, according to DelveInsight estimates, global breast cancer incidence was approximately 2.29 million cases in 2022 and is projected to increase to 3.36 million cases by 2045, underscoring the importance of advanced diagnostic modalities.

Growing Preference for Minimally Invasive Procedures
Healthcare providers and patients increasingly prefer minimally invasive procedures that reduce pain, recovery time, and complication risks. Techniques such as core needle biopsy, fine-needle aspiration (FNA), vacuum-assisted biopsy (VAB), and image-guided approaches are witnessing widespread adoption. These methods improve diagnostic precision while enhancing patient comfort, fueling demand across hospitals and outpatient facilities.

Technological Advancements
Rapid innovation is reshaping the biopsy devices market. Recent advancements include:
• Vacuum-assisted systems for improved tissue sampling.
• Robotic-assisted biopsy platforms that enhance precision.
• Image-guided biopsy techniques integrated with CT, MRI, and ultrasound.
• AI-powered digital pathology solutions, enabling real-time analysis and diagnostic support.

For instance, in January 2025, Biobot Surgical's Mona Lisa 2.0 robotic system received CE certification. Specifically designed for prostate biopsy and ablation, the system integrates real-time trajectory adjustments to reduce tissue injury and improve procedural accuracy.

Discuss Biopsy Devices market trends, growth drivers, and competitor strategies with our healthcare market experts - https://www.delveinsight.com/sample-request/biopsy-devices-market?utm_source=openpr&utm_medium=press-release&utm_campaign=apr

Biopsy Devices Market Size and Segmentation
• 2024 Market Size: USD 5,813.16 million
• 2032 Market Size Projection: USD 10,812.77 million
• CAGR (2025-2032): 8.09%

The biopsy devices market is moderately to highly consolidated, with leading companies such as Boston Scientific Corporation, Cardinal Health, Medtronic, BD, Cook, Hologic Inc., Olympus Corporation, Fujifilm, B. Braun Melsungen AG, Devicor Medical Products, ARGON Medical, and C. R. Bard spearheading technological innovations and product development activities.

Biopsy Devices Market By Product Type
• Needle-based Biopsy Instruments - Dominating the segment with ~39% share in 2024. Core needle, fine-needle aspiration, and vacuum-assisted devices are increasingly used in cancer and infectious disease diagnosis.
• Biopsy Guidance Systems
• Robotic Biopsy Devices
• Biopsy Accessories

Biopsy Devices Market By Application
• Breast Biopsy - Leading with ~30% market share in 2024, driven by rising global breast cancer incidence and emphasis on early detection.
• Lung Biopsy
• Colorectal Biopsy
• Prostate Biopsy
• Others

Biopsy Devices Market By End-User
• Hospitals - Largest share, owing to high diagnostic procedure volumes and availability of skilled professionals.
• Diagnostic Centers & Imaging Centers
• Ambulatory Surgical Centers

Gain a strategic edge with our in-depth biopsy devices market analysis and custom research solutions. Get Customized Insights - https://www.delveinsight.com/report-store/biopsy-devices-market?utm_source=openpr&utm_medium=press-release&utm_campaign=apr

Biopsy Devices Market Regional Insights
North America Biopsy Devices Market
North America is expected to dominate the global biopsy devices market, accounting for approximately 41% of the total share in 2024. Factors contributing to this leadership include a high prevalence of cancer, well-established healthcare infrastructure, favorable reimbursement policies, and strong adoption of advanced diagnostic technologies. Government-led screening initiatives and the presence of major device manufacturers further strengthen the region's dominance.

According to estimates, North America recorded 306,308 new breast cancer cases in 2022, projected to rise to 384,262 by 2045. Increasing adoption of minimally invasive techniques, along with innovations in AI-powered digital pathology, is propelling regional market growth.

Europe Biopsy Devices Market
Europe is experiencing strong growth due to supportive healthcare infrastructure, government-backed cancer screening programs, and investments in personalized medicine. Breast cancer incidence continues to rise, driving demand for reliable biopsy techniques. Advanced diagnostic technologies and strong clinical adoption are fostering significant opportunities in the region.

Asia-Pacific Biopsy Devices Market
The Asia-Pacific region represents the fastest-growing market for biopsy devices. Rising cancer prevalence, growing awareness of early detection, expanding healthcare infrastructure, and increasing investments in diagnostic facilities are driving adoption. Countries such as China, India, and Japan are emerging as key markets due to large patient pools and rising healthcare expenditure.

Access data-driven insights on biopsy devices market size, segmentation, and regional trends. Download Full Report - https://www.delveinsight.com/sample-request/biopsy-devices-market?utm_source=openpr&utm_medium=press-release&utm_campaign=apr

Biopsy Devices Competitive Landscape
The biopsy devices market is moderately to highly consolidated. Global leaders such as Becton Dickinson, Hologic, Boston Scientific, and Cook Medical dominate through strong R&D pipelines and technological innovation. Strategies such as mergers, acquisitions, partnerships, and new product launches are shaping competition.
• In July 2025, Selio Medical received FDA clearance for its Pre-B. Seal device, the first system designed to reduce post-lung biopsy pneumothorax, improving patient safety.
• In April 2025, ArteraAI Prostate received FDA authorization for its AI-powered pathology tool that predicts long-term prostate cancer outcomes.
• In February 2025, Ibex Medical Analytics secured FDA clearance for its Ibex Prostate Detect, an AI-driven digital pathology solution.
Regional players and startups are also entering the market with cost-effective solutions, targeting emerging economies and niche applications.

Stay updated on how leaders like Boston Scientific, Medtronic, BD, Hologic, and Olympus are reshaping the biopsy devices market with groundbreaking innovations, regulatory approvals, and strategic acquisitions. Discover the Full Competitive Landscape - https://www.delveinsight.com/report-store/biopsy-devices-market?utm_source=openpr&utm_medium=press-release&utm_campaign=apr

Biopsy Devices Market Opportunities and Challenges
Biopsy Devices Market Opportunities
• Rising global cancer prevalence and screening programs.
• Increasing demand for AI-powered biopsy guidance and digital pathology.
• Expansion into emerging markets with growing healthcare infrastructure.

Biopsy Devices Market Challenges
• High cost of advanced robotic and image-guided systems.
• Regulatory complexities delaying product launches.
• Competition from non-invasive alternatives such as liquid biopsy.
• Shortage of trained healthcare professionals to operate advanced systems.

Analysts Commentary on Biopsy Devices Market
The biopsy devices market is undergoing rapid transformation, fueled by rising cancer incidence, demand for minimally invasive diagnostics, and cutting-edge technological innovations. North America continues to dominate the global landscape, while Asia-Pacific emerges as the fastest-growing region. With AI integration, robotic platforms, and digital pathology set to redefine diagnostics, the biopsy devices market will remain a cornerstone of global cancer detection and management through 2032.

Contact Us:
Ankit Nigam
Manager Marketing
info@delveinsight.com
+14699457679

About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.

This release was published on openPR.